NHHA comments on HRSA proposed regulation implementing the Patient Protection and Affordable Care Act (ACA) provision that excludes orphan drugs for purchase under the 340B drug discount program for some types of hospitals, including Critical Access Hospitals (CAHs), rural referral centers (RRCs) and sole community hospitals (SCHs).

NHHA supports HRSA's interpretation of the ACA's orphan drug exclusion and agrees with their more narrow interpretation of the ACA orphan drug exclusion. The 340B drug discount program is an important tool for safety-net hospitals to manage drug costs while serving the needs of vulnerable patients